Evidence map›Paper›PMID 34046222›Full record

ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2021

Feasibility and potential advantages using VMAT in SRS metastasis treatments.

Maria Jose Perez-Calatayud, Antonio Vicente Menendez, Francisco Javier Celada-Alvarez, Antonio Jose Conde-Moreno, Mariola Bernisz, Françoise Lliso, Vicente Carmona, Jose Gimeno-Olmos, Carlos Botella, Jose Perez-Calatayud

Open access · diamondAbstract read
In one paragraph

Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Maria Jose Perez-CalatayudRadiotherapy Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
Antonio Vicente MenendezNeurosurgery Department, Hospital La Fe, Valencia, Spain.
Francisco Javier Celada-AlvarezRadiotherapy Department, Hospital La Fe, Valencia, Spain.
Antonio Jose Conde-MorenoRadiotherapy Department, Hospital La Fe, Valencia, Spain.
Mariola BerniszRadiotherapy Department, Hospital La Fe, Valencia, Spain.
Françoise LlisoRadiotherapy Department, Hospital La Fe, Valencia, Spain.
Vicente CarmonaRadiotherapy Department, Hospital La Fe, Valencia, Spain.
Jose Gimeno-OlmosRadiotherapy Department, Hospital La Fe, Valencia, Spain.
Carlos BotellaNeurosurgery Department, Hospital La Fe, Valencia, Spain.
Jose Perez-CalatayudRadiotherapy Department, Hospital La Fe, Valencia, Spain.
Leitat Technological Center · ESFundación Instituto Valenciano de Oncología · ESHospital Clínica Benidorm · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUtilization of stereotactic radiosurgery (SRS) for brain metastases (BM) has become the technique of choice as opposed to whole brain radiation therapy (WBRT). The aim of this work is to evaluate the feasibility and potential benefits in terms of normal tissue (NT) and dose escalation of volumetric modulated arc therapy (VMAT) in SRS metastasis treatment. A VMAT optimization procedure has therefore been developed for internal dose scaling which minimizes planner dependence. MATERIALS AND

methodsFive patient-plans incorporating treatment with frame-based SRS with dynamic conformal arc technique (DA) were re-planned for VMAT. The lesions selected were between 4-6 cm

resultsVMAT allows a superior NT sparing plus conformity and dose scaling using the auxiliary volumes. The VMAT results were significantly superior in NT sparing, improving both the V

conclusionsThis work shows a benefit of VMAT in SRS treatment with significant NT sparing. A VMAT optimization procedure, based on auxiliary inner volumes, has been developed, enabling internal dose escalation.

Indexed as

clinical dosimetrymetastasisradiotherapySRSVMAT

Identifiers

PMID34046222
PMCPMC8149131
OpenAlexW3127857112

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.